Produktbild: Role of Gut Microbiome in Neurodegenerative Disorders
- 13%

Role of Gut Microbiome in Neurodegenerative Disorders

13% sparen

166,99 € UVP 192,30 €

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

29.09.2025

Herausgeber

Mukesh Kumar Yadav + weitere

Verlag

Elsevier Science & Technology

Seitenzahl

336

Maße (L/B/H)

22,8/15,2/1,8 cm

Gewicht

540 g

Sprache

Englisch

ISBN

978-0-443-29932-2

Beschreibung

Portrait

Dr. Mukesh Kumar Yadav is working as Professor at the Department of Microbiology, Central University of Punjab, Bathinda, India. Prof. Yadav has more than 15 years of research experience in medical microbiology, particularly in microbial biofilms and host-microbial interactions. Prof. Yadav has published over 110 research articles, garnering more than 7,000 citations, and has authored five books with Elsevier. He has completed eight major research projects funded by the Indian Council of Medical Research (ICMR), the Department of Biotechnology (DBT), the Department of Science and Technology (DST), and the National Research Foundation (South Korea). Prof. Yadav's research area focuses on host-microbial interactions and microbial biofilms, including pathogenic and commensal bacteria in the gut. Prof. Yadav's lab is working on understanding microbial biofilms and infections caused by the biofilm mode of growth, as well as antimicrobial resistance (AMR), and identifying suitable strategies to combat AMR and drug resistance. Understanding Commensal Bacterial Interaction and Dysbiosis of Gut Microbiota during Various Metabolic Disorders.

Dr. Balachandar Vellingiri currently is investigating various neurological diseases and developing human induced pluripotent stem cells (HiPSCs). Exploring the cutting-edge molecular, cellular, and translational neuroscience approaches, he aims to unravel disease mechanisms, identify therapeutic targets, and develop innovative interventions to slow or reverse neurological diseases. His expertise is on several techniques such as molecular cytogenetics, pathway analysis, and techniques in developing HiPSCs and Brain organoids, especially for neurological diseases.

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

29.09.2025

Herausgeber

Verlag

Elsevier Science & Technology

Seitenzahl

336

Maße (L/B/H)

22,8/15,2/1,8 cm

Gewicht

540 g

Sprache

Englisch

ISBN

978-0-443-29932-2

EU-Ansprechpartner

Zeitfracht Medien GmbH
Ferdinand-Jühlke-Straße 7
99095 Erfurt
DE
produktsicherheit@zeitfracht.de

Herstelleradresse

Elsevier Science & Technology
London Wall 125
EC2Y 5AS London
GB
tradeorders@elsevier.com

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

Die Leseprobe wird geladen.
  • Produktbild: Role of Gut Microbiome in Neurodegenerative Disorders
  • 1. Overview of Neurodegenerative Disorders
    2. Gut Microbiota and Neurological Diseases
    3. Gut-Brain Axis
    4. Gut-Brain Axis in Neurological Diseases
    5. Difference in the constitution of Gut Microbiota during Neurodegenerative Disorders
    6. Gut Metabolites in Neurodegenerative Diseases
    7. Influence of Gut Microbiota on Cerebellum
    8. Influence of Gut Microbiota on Hippocampus
    9. Influence of Gut Microbiota on Axonal Cells of the brain
    10. Mechanistic action of Gut Microbiota on Glial cells
    11. Gut as a second brain- Largest producer of serotonin
    12. Gradual Shift of gut microbial Population as a diagnostic marker for Neurodegenerative disorders
    13. Gut metabolites - effective biomarker for Neurodegenerative disorder
    14. Protocol - Isolation of Gut Microbiome from Faecal sample
    15. Gut metabolites isolation from Blood
    16. Metagenomics and sequence analysis
    17. Computer aided detection method
    18. Existing therapeutic options to alter gut composition in Neurodegenerative Disorders
    19. Dietary and Gut microbiome
    20. Ongoing clinical trials
    21. Ethical hurdles for the treatment of a disease focusing Gut Microbiota
    22. Futuristic therapies in pipeline for the betterment of Neurodegenerative Disorders